FARMACOSMO SPA (COSMO.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:COSMO • IT0005487670
0.606 EUR
-0.02 (-3.5%)
Last: Jan 30, 2026, 07:00 PM
COSMO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 59 industry peers in the Specialty Retail industry. COSMO may be in some trouble as it scores bad on both profitability and health. COSMO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- COSMO had negative earnings in the past year.
- In the past year COSMO has reported a negative cash flow from operations.
- In multiple years COSMO reported negative net income over the last 5 years.
- COSMO had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- COSMO has a worse Return On Assets (-16.93%) than 87.72% of its industry peers.
- COSMO has a worse Return On Equity (-65.88%) than 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.93% | ||
| ROE | -65.88% | ||
| ROIC | N/A |
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 5.88%, COSMO is not doing good in the industry: 87.72% of the companies in the same industry are doing better.
- COSMO's Gross Margin has improved in the last couple of years.
- COSMO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
2. Health
2.1 Basic Checks
- COSMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- COSMO has about the same amout of shares outstanding than it did 1 year ago.
- COSMO has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, COSMO has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 1.89 indicates that COSMO is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of COSMO (1.89) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.84 indicates that COSMO is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.84, COSMO is doing worse than 61.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.89 |
ROIC/WACCN/A
WACC7.09%
2.3 Liquidity
- A Current Ratio of 1.22 indicates that COSMO should not have too much problems paying its short term obligations.
- COSMO has a Current ratio (1.22) which is in line with its industry peers.
- COSMO has a Quick Ratio of 1.22. This is a bad value and indicates that COSMO is not financially healthy enough and could expect problems in meeting its short term obligations.
- COSMO's Quick ratio of 0.50 is in line compared to the rest of the industry. COSMO outperforms 47.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.5 |
3. Growth
3.1 Past
- COSMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.41%.
- The Revenue for COSMO has decreased by -12.95% in the past year. This is quite bad
- Measured over the past years, COSMO shows a very strong growth in Revenue. The Revenue has been growing by 20.99% on average per year.
EPS 1Y (TTM)-98.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.3%
Revenue 1Y (TTM)-12.95%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-14.57%
3.2 Future
- The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
- Based on estimates for the next years, COSMO will show a quite strong growth in Revenue. The Revenue will grow by 13.48% on average per year.
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for COSMO. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as COSMO's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for COSMO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FARMACOSMO SPA / COSMO.MI FAQ
What is the ChartMill fundamental rating of FARMACOSMO SPA (COSMO.MI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to COSMO.MI.
Can you provide the valuation status for FARMACOSMO SPA?
ChartMill assigns a valuation rating of 1 / 10 to FARMACOSMO SPA (COSMO.MI). This can be considered as Overvalued.
What is the profitability of COSMO stock?
FARMACOSMO SPA (COSMO.MI) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for COSMO stock?
The Earnings per Share (EPS) of FARMACOSMO SPA (COSMO.MI) is expected to grow by 33.33% in the next year.